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DesignMechanical heart valve prostheses are based on older designs without changes during the last 40 years. Today,
there is an unmet need for less thrombogenic mechanical prostheses. Analysis of the relationship between
flow characteristics and thromboembolic complications is possible using numerical and biomolecular flow stud-
ies that have shown that the reverse rather than the forward flow is responsible for local platelet activation and
thrombosis. After peak flow, leaflets experience flow deceleration and the leaflets are still widely openwhen the
flow becomes zero. The closure of the valve starts with the onset of reverse flow. Therefore, the valve closes ex-
tremely fast with most of the leaflet traveling angle occurring in b10 ms with excessively high reverse flow ve-
locities. The pivoting spaces, so-called “Hot Spots” should be eliminated to prevent pathologic shear stress that
result in thrombosis. A novel tri-leaflet valve combines favorable hemodynamics with the durability of mechan-
ical heart valve. This valve closeswithin 60ms,much slower than bi-leaflet valves and similar to the closingmode
of a tissue valve. Micro-particle image velocimetry did not show critical regions of flow stagnation and zones of
excessive shear in the pivoting region suggesting low potential for thrombogenic events that should allow to
avoid long-term anticoagulation.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Current bi-leaflet mechanical valves based on a design developed in
the early 1970s with the assumption that damage to blood cells and
thrombogenic activation occur during forward flow. In contrast to the
energy efficient central flow of human valves, caged-ball valves of the
1960s obstructed central flow and were replaced by tilting-disc valves
and later by bi-leaflet pyrolytic carbon valves; the latter became the
gold standard [1]. Since then, there has been little progress in the design
of mechanical heart valves.
Minimizing the energy required to eject the blood through the valve
did not eliminate activation of the coagulation cascade. Therefore, cur-
rent bi-leaflet mechanical valves still require life-long anticoagulation.
Although inexpensive, Warfarin increases bleeding risk and does notlar, Surgery University Hospital,
. This is an open access article underaddress the real problem of mechanical heart valves. New anticoagu-
lants were recently disqualified by clinical trials [2].
Advanced experimental, numerical and biomolecular blood flow
studies have shown that the reverse rather than the forward flow
phase is responsible for local platelet activation and thrombosis [3,4].
These insights on thrombogenicity of mechanical heart valves have
been overlooked so far. Indeed, the medical community still believes
that oral anticoagulation in patients with mechanical heart valves is re-
quired because foreign material is exposed to the blood flow.
Modifying closing characteristics and hinge mechanisms by a tri-
leaflet mechanical valve design may reduce thromboembolic complica-
tions and will make need for long-term Warfarin therapy unnecessary.
Soluble agonists of the coagulation cascade initiate platelet aggrega-
tion and thrombus growth (“biochemical coagulation”) in mechanical
heart valves.High resolution intra-vital imaging techniques and numer-
ical hydrodynamic analyses confirm that platelet aggregation isthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Left. Closing mode comparing a tissue valve (yellow) with a mechanical bi-leaflet valve (red). The St Jude valve is wide open at zero flowwhile the tissue valve (CE) is fully closed.
Right. Closingmode comparing a tissue valve (yellow)with amechanical tri-leaflet valve (green). The tri-leaflet valve closingmechanism is rather similar to that of a tissue valve (CE). Left
is valve opening and right valve closure.
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thrombosis”) [5].
Shear stresses during valve closure of current bi-leaflet prostheses
are much higher than those required to stimulate platelet activation
[1]. Platelets exposed to excessive shear stress instantaneously develop
membrane tethers, leading to transient platelet aggregates. Upon subse-
quent exposure to low-flow conditions or flow stagnation, filamentous
tethers physically restructure, increasing the strength and stability of
platelet aggregates, thereby promoting thrombus growth. Simulta-
neously, large thrombi formon substrates that are not covered by endo-
thelial cells from local release and conformational changes of von
Willebrand factor with explosive (b10 microsec) binding to specific
platelet receptors (20,000 GPI b sites on each platelets) and “Velcro-
like” capture of billions of platelets.
The bi-leaflet valve cannot close without reverse flow because flow
deceleration in late systole does not generate sufficient closing pressure.
Unlike the leaflets of a native or tissue valve, the carbon leaflets start
closing with the onset of reverse flow (Fig. 1) which accelerates rapidly
due to the low pressure in the relaxing ventricle. This non-physiologic
closing mode leads to significant backflow during the closing process.
Moreover, the valve closes extremely fast and exhibits leaflet rebound.
Experimental studies report 75% of the leaflet traveling angle occurring
in b3 ms and reverse flow velocities as high as 200 m/s (approximately
700 km/h) [3]. For a short period of time, this leads to extremely low
pressures.When pressure goes below the vapor pressure, blood is “boil-
ing” for few microseconds – a process known as cavitation - and the
formed micro-bubbles “implode” when pressure recovers with a con-
siderable energy release that can damage or even destroy solid surfaces.
At the same time, nitrogen and carbon dioxide are extracted from the
blood and bubbles with a longer lifespan are detected downstream in
the brain (HITS: High Intensity Transient Signal) [6].
After closing, aortic pressure leads to a leakage flow through the nar-
row gaps in the hinge recesses of bi-leaflet valves. Like the non-
physiologic closing mode, this leakage flow leads to shear-induced
thrombosis in the hinge region, which may immobilize one leaflet or
the entire valve [4]. This phenomenon has been thoroughly investigated
by modern computational methods and high-velocity jets in the hinge
regions were identified with velocities higher than 5 m/s leading to
shear stresses beyond 100 Pa. Platelets are activated in these high
shear regions and get trapped in low shear regions in the vicinity of
the hinges.
Better design of mechanical valves must ensure smooth closing dur-
ing flow deceleration to prevent reverse flow and eliminate high-shear
hinge flow during diastole. Tissue valves addressed the problem of
thromboembolic complications of mechanical valves and the disadvan-
tage of anticoagulation. The concept consisted in retaining the design
advantages of the native valves. The tissue valves do not carry such a
risk because of the soft closing mode during flow deceleration (Fig. 1)
and because there is no leaking hinge for the leaflets. Their lowthrombogenicity is not material related. Glutaraldehyde fixation
makes biologic tissues hydrophobic similar to foreign materials com-
monly used inmechanical valves; its toxicity results in poor endothelial
cells adhesion and therefore cross-linked bovine or porcine collagen
materials have no bioactive protection against thrombosis. This is the
reason why oral anticoagulation is still recommended in the early
phase (3–6 months) following tissue valve implantation.
A new tri-leaflet valve design (Lapeyre-Triflo Valve, Novostia,
Switzerland) is much more similar to that of a biological valve than a
bi-leaflet valve (Fig. 1). It combines the favorable hemodynamics of
bioprosthetic heart valves with the durability of mechanical heart
valves. Computational and in vitro studies indicated that this valve
closes much slower than bi-leaflet valves and similar to the closing
mode of a tissue valve (Fig. 1) [7,8]. Studies using micro-PIV were un-
able to identify any critical zones of excessive shear in the pivoting re-
gion, suggesting a lower thrombogenic potential compared to classical
recessed hinge designs [9].
Recent efforts have focused on development of tissue valves for
trans-catheter implantation only. However, there is still a worldwide
unmet need for more durable and less thrombogenic heart valves, par-
ticularly for younger patients including children and women in child-
bearing age suffering from congenital or rheumatic valve disease.
The Tri-Flo valve is a novel valve concept towards a Warfarin-free
mechanical heart valve that combines optimal function, minimal
blood particle injury and predictable long-term performance. This will
challenge the trans-catheter valves.
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